Tech Company Financing Transactions
hema.to Funding Round
On 3/6/2025, hema.to raised $3.9 million in funding from LUMO Labs, Bayern Kapital and private investors.
Transaction Overview
Company Name
Announced On
3/6/2025
Transaction Type
Venture Equity
Amount
$3,900,000
Round
Undisclosed
Investors
LUMO Labs (Lead Investor)
Proceeds Purpose
The company intends to use the funds to refine product-market-fit in their first segment of blood cancer diagnostics, including additional European certification, and for clinical studies, expansion into diagnosis of broader immune disorders, and scaling commercial deployment.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Metzstr. 14B
Munich, 81667
Germany
Munich, 81667
Germany
Phone
Undisclosed
Website
Email Address
Overview
We are a deeptech AI company obsessed with solving cytometry and thereby make an outsized and lasting impact on immune medicine: we want to make sure every patient gets the right treatment at the right time for their unique immune systems.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Karsten Miermans
Browse more venture capital transactions:
Prev: 3/6/2025: GovEagle venture capital transaction
Next: 3/6/2025: Ataraxis AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs